A city-based medtech firm has secured investment of €6.4m to advance a revolutionary new stroke treatment.
Ceroflo will use the latest funding to advance an innovative stent that works to prevent one of the leading causes of stroke.
That's Intracranial atherosclerotic disease - or IACD.
The €6.4m will now allow Ceroflo to bring the stent to 30 patients in the first human trials.
Galway Bay FM News provides trusted, comprehensive coverage and analysis of local, national, and international stories.
Tune in every hour, Monday to Friday, 7am to 6pm, with breakfast updates at 7:30 and 8:30.
Catch the multi-award-winning FYI Galway from 5pm for all your news and sport, along with traffic and business information.
Download the Galway Bay FM app to get the latest stories on the go and stay connected on Facebook, Instagram and X
